Association of cord blood magnesium concentration and neonatal resuscitation

Lynn H. Johnson*, Delicia C. Mapp, Dwight J. Rouse, Catherine Y. Spong, Brian M. Mercer, Kenneth J. Leveno, Michael W. Varner, Jay D. Iams, Yoram Sorokin, Susan M. Ramin, Menachem Miodovnik, Mary J. O'Sullivan, Alan M. Peaceman, Steve N. Caritis

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

Objective: To assess the relationship between umbilical cord blood magnesium concentration and level of delivery room resuscitation received by neonates. Study design: This was a secondary analysis of a controlled fetal neuroprotection trial that enrolled women at imminent risk for delivery between 24 and 31 weeks' gestation and randomly allocated them to receive either intravenous magnesium sulfate or placebo. The cohort included 1507 infants with data available on total cord blood Mg concentration and delivery room resuscitation. Multivariate logistic regression was used to estimate the association between cord blood Mg concentration and highest level of delivery room resuscitation, using the following hierarchy: none, oxygen only, bag-mask ventilation with oxygen, intubation, and chest compressions. Results: There was no relationship between cord blood Mg and delivery room resuscitation (OR, 0.92 for each 1.0-mEq/L increase in Mg; 95% CI, 0.83-1.03). Maternal general anesthesia was associated with increased neonatal resuscitation (OR, 2.51; 95% CI, 1.72-3.68). Each 1-week increase in gestational age at birth was associated with decreased neonatal resuscitation (OR, 0.63; 95% CI, 0.60-0.66). Conclusion: Cord blood Mg concentration does not correlate with the level of delivery room resuscitation of infants exposed to magnesium sulfate for fetal neuroprotection.

Original languageEnglish (US)
Pages (from-to)573-577.e1
Journaljournal of pediatrics
Volume160
Issue number4
DOIs
StatePublished - Apr 2012

Funding

We thank the subcommittee members who participated in protocol development and coordination between clinical research centers (Allison T. Northen, MSN, RN), protocol/data management and statistical analysis (Elizabeth Thom, PhD and Steven J. Weiner, MS), and protocol development and oversight (Deborah G. Hirtz, MD and John M. Thorp, Jr, MD). We also thank Matthew M. Laughon, MD, MPH (supported by the US government for his work in pediatric and neonatal clinical pharmacology [ National Institutes of Health Grant 1K23HL092225-01 ]), University of North Carolina at Chapel Hill, for providing additional support with analysis and manuscript review.

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Association of cord blood magnesium concentration and neonatal resuscitation'. Together they form a unique fingerprint.

Cite this